drugset / Trial / NCT04039724

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

NCT04039724

Phase 1 Completed 61 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the pharmacokinetics and safety/tolerability after administration of HCP1305 and co-administration of HCP0605, HGP0816 in healthy male volunteers

Timeline

Start
2015-02
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP0605 Unknown
Subject HCP1305 Unknown
Subject HGP0816 Unknown

Indications

No indication recorded.